SPAC16C9.05 Antibody

What is SPAC16C9.05 and what cellular functions does it regulate in S. pombe?

SPAC16C9.05 is a gene in Schizosaccharomyces pombe (fission yeast) that encodes a protein involved in cellular processes. While specific information about SPAC16C9.05 is limited in the provided search results, antibodies against S. pombe proteins are valuable tools for studying gene function and protein localization. Similar to the characterized S. pombe proteins mentioned in the search results (such as SPBC119.16c), SPAC16C9.05 likely participates in yeast cellular pathways that can be investigated through antibody-based detection methods .

Researchers typically use these antibodies to:

• Track protein expression levels under different conditions

• Determine subcellular localization

• Identify protein-protein interactions

• Study post-translational modifications

What applications are SPAC16C9.05 antibodies commonly used for in yeast research?

SPAC16C9.05 antibodies are primarily used in fundamental research applications to understand protein function in S. pombe. Based on common applications of similar research antibodies, SPAC16C9.05 antibodies would typically be used for:

• Western blotting - To detect protein expression levels and molecular weight

• Immunoprecipitation - To isolate protein complexes

• Immunofluorescence microscopy - To visualize subcellular localization

• Chromatin immunoprecipitation (ChIP) - If the protein has DNA-binding properties

• ELISA - For quantitative protein detection

Similar to antibodies mentioned in the search results, SPAC16C9.05 antibody would be characterized and validated for specific applications prior to experimental use .

How should SPAC16C9.05 antibody be stored and handled to maintain optimal activity?

Based on standard antibody storage conditions similar to those mentioned in search result , SPAC16C9.05 antibody should be stored as follows:

• Temperature: 2-8°C for short-term storage (typically up to 1 month)

• For long-term storage: Aliquot and store at -20°C or -80°C to avoid freeze-thaw cycles

• Buffer conditions: Typically in phosphate-buffered saline (PBS) with glycerol (often 50% glycerol/50% PBS at pH 7.4)

• Preservatives: May contain 0.02% sodium azide or other preservatives

• Light exposure: Protect conjugated antibodies from light

Proper handling includes avoiding repeated freeze-thaw cycles (no more than 5), centrifuging briefly before opening vials, and using clean pipette tips to prevent contamination.

How can SPAC16C9.05 antibody be used in combination with genomic studies to investigate protein-DNA interactions?

For researchers investigating SPAC16C9.05 protein-DNA interactions, integrating antibody-based approaches with genomic techniques provides comprehensive insights. A methodological approach would include:

• ChIP-seq Protocol Optimization:

  • Fixation: Optimize formaldehyde crosslinking time (typically 10-15 minutes) for S. pombe cells

  • Sonication: Determine optimal sonication conditions to achieve 200-500 bp DNA fragments

  • Immunoprecipitation: Use 2-5 μg of SPAC16C9.05 antibody per 25 μg of chromatin

  • Controls: Include IgG control antibodies and input samples

• Data Analysis Pipeline:

  • Align sequencing reads to the S. pombe reference genome

  • Identify enriched regions using peak calling algorithms (MACS2)

  • Perform motif analysis to identify DNA binding motifs

  • Integrate with RNA-seq data to correlate binding with gene expression

• Validation Approaches:

  • Confirm binding sites with ChIP-qPCR

  • Use EMSA (Electrophoretic Mobility Shift Assay) to validate direct binding

  • Perform mutagenesis studies of predicted binding motifs

This approach mirrors advanced antibody applications seen in studies like those mentioned in search result , where antibody characterization led to deeper mechanistic insights.

What are the optimal conditions for using SPAC16C9.05 antibody in co-immunoprecipitation experiments to identify protein interaction networks?

When using SPAC16C9.05 antibody for co-immunoprecipitation (co-IP) experiments to map protein interaction networks in S. pombe, researchers should consider the following methodological details:

Optimized Co-IP Protocol:

• Cell Lysis Buffer Selection:

  • Basic lysis buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40

  • Add protease inhibitors: Complete Protease Inhibitor Cocktail

  • Include phosphatase inhibitors if studying phosphorylation-dependent interactions

  • Consider mild detergents (0.1% NP-40 or 0.5% Triton X-100) to preserve weak interactions

• Antibody Coupling Strategy:

  • Direct approach: Couple 5-10 μg SPAC16C9.05 antibody to 50 μl Protein A/G beads

  • Pre-clearing step: Incubate lysate with beads alone before antibody addition

  • Cross-linking option: Use BS3 or DSS to cross-link antibody to beads (prevents antibody co-elution)

• Washing and Elution Optimization:

  • Washing stringency gradient: Test multiple salt concentrations (150-500 mM NaCl)

  • Elution methods: Compare acidic elution (0.1 M glycine, pH 2.5) vs. SDS elution vs. competitive elution with peptides

  • Native elution: Consider on-bead digestion for mass spectrometry

• Controls and Validation:

  • Negative control: Non-specific IgG of same species and isotype

  • Reverse co-IP: Confirm interactions using antibodies against suspected binding partners

  • Input control: Load 5-10% of pre-IP lysate

Similar to the approach taken in search result where mass spectrometry was used to confirm specific binding of Abs-9 antibody to SpA5, researchers should validate interactions through multiple methodologies.

How can phospho-specific versions of SPAC16C9.05 antibodies be evaluated for specificity and sensitivity?

When working with phospho-specific SPAC16C9.05 antibodies, rigorous validation is essential to ensure specificity for the phosphorylated form of the protein. A comprehensive evaluation should include:

• In vitro Validation:

  • Peptide competition assays: Compare binding to phosphorylated vs. non-phosphorylated peptides

  • Dot blot analysis: Test antibody against serial dilutions of phospho- and non-phospho-peptides

  • Western blot comparison: Analyze samples treated with or without phosphatase

• Cellular Validation:

  • Phosphorylation induction: Treat cells with stimuli known to induce specific phosphorylation

  • Kinase inhibition: Confirm signal reduction when relevant kinase is inhibited

  • Site-directed mutagenesis: Create serine/threonine to alanine mutations to eliminate phosphorylation sites

• Cross-reactivity Assessment:

  • Test against similar phosphorylation motifs in other proteins

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

This methodological approach is similar to antibody characterization described in search result , where multiple validation methods were used to confirm antibody specificity.

What are the optimal conditions for Western blotting using SPAC16C9.05 antibody with S. pombe lysates?

Based on common practices for S. pombe proteins and information from search results about antibody applications, here is a detailed Western blotting protocol for SPAC16C9.05 antibody:

Sample Preparation:

• Harvest 10-20 ml of S. pombe culture (OD600 = 0.5-1.0)

• Lyse cells using glass beads in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 5 mM EDTA) with protease inhibitors

• Centrifuge at 12,000 × g for 15 minutes at 4°C and collect supernatant

• Quantify protein concentration using Bradford or BCA assay

Gel Electrophoresis and Transfer:

• Load 20-40 μg of protein per lane on 10-12% SDS-PAGE gel

• Include positive control (if available) and molecular weight marker

• Run gel at 100-120V until dye front reaches bottom

• Transfer to PVDF membrane (pre-activated with methanol) at 100V for 1 hour or 30V overnight at 4°C

Immunoblotting:

• Block membrane in 5% non-fat dry milk in TBST for 1 hour at room temperature

• Incubate with SPAC16C9.05 antibody at 1:1000 dilution in blocking buffer overnight at 4°C

• Wash 3 × 10 minutes with TBST

• Incubate with appropriate HRP-conjugated secondary antibody (1:5000 dilution) for 1 hour at room temperature

• Wash 3 × 10 minutes with TBST

• Develop using ECL substrate and image using digital imager or film

Optimization Tips:

• Test multiple antibody dilutions (1:500 to 1:5000) to determine optimal signal-to-noise ratio

• If high background occurs, increase blocking (overnight at 4°C) and add 0.1-0.5% Tween-20 to antibody dilution buffer

• For weak signals, extend primary antibody incubation and/or use signal enhancement systems

This protocol draws on standard approaches similar to those referenced for antibody applications in search result .

How should immunofluorescence experiments be designed when using SPAC16C9.05 antibody for subcellular localization studies?

For effective immunofluorescence microscopy using SPAC16C9.05 antibody in S. pombe, researchers should follow this methodological approach:

Fixation and Permeabilization Optimization:

• Compare multiple fixation methods:

  • Formaldehyde fixation (4%, 10-15 minutes at room temperature)

  • Methanol fixation (-20°C, 6 minutes) for certain epitopes

  • Combined formaldehyde-methanol for challenging epitopes

• Permeabilization options:

  • 0.1% Triton X-100 in PBS (10 minutes)

  • 0.5% Tween-20 in PBS (15 minutes)

  • Enzymatic digest with Zymolyase (specific for yeast cell walls, 10-30 minutes at 37°C)

Antibody Incubation Protocol:

• Block with 5% BSA or normal serum from secondary antibody species (1 hour)

• Incubate with SPAC16C9.05 antibody (1:50 to 1:500 dilution, overnight at 4°C)

• Wash 3 × 5 minutes with PBS + 0.1% Tween-20

• Incubate with fluorophore-conjugated secondary antibody (1:500, 1 hour at room temperature)

• Counterstain with DAPI (1 μg/ml for 5 minutes)

• Mount with anti-fade mounting medium

Controls and Validation:

• Include negative control (secondary antibody only)

• Use peptide competition control to confirm specificity

• Include positive control (co-staining with known marker of expected compartment)

• Consider testing GFP-tagged version of SPAC16C9.05 for comparison

Co-localization Studies:

This approach is similar to immunohistochemistry applications mentioned in search result , adapted specifically for yeast cells.

What methods can be used to validate SPAC16C9.05 antibody specificity in S. pombe?

Comprehensive antibody validation is essential for ensuring reliable experimental results. For SPAC16C9.05 antibody, researchers should employ the following validation strategy:

Genetic Validation Approaches:

• Knockout/Deletion Strains:

  • Compare antibody signal between wild-type and SPAC16C9.05 deletion strains

  • Expected outcome: Complete absence of signal in deletion strain confirms specificity

• Tagged Protein Expression:

  • Create strains expressing epitope-tagged SPAC16C9.05 (e.g., GFP, FLAG, HA)

  • Perform parallel detection with anti-tag antibody and SPAC16C9.05 antibody

  • Expected outcome: Co-localization of signals confirms target identity

Biochemical Validation Methods:

• Western Blot Analysis:

  • Confirm single band of expected molecular weight

  • Compare to bioinformatic prediction of protein size

  • Test multiple antibody concentrations for optimal specificity

• Immunoprecipitation-Mass Spectrometry:

  • Perform IP with SPAC16C9.05 antibody

  • Analyze pulled-down proteins by mass spectrometry

  • Expected outcome: Enrichment of SPAC16C9.05 protein

• Peptide Competition Assay:

  • Pre-incubate antibody with immunizing peptide

  • Compare signal with and without peptide competition

  • Expected outcome: Significant signal reduction with specific peptide

This approach mirrors the validation strategy described in search result , where researchers used multiple methods to confirm antibody specificity, including mass spectrometry detection to verify binding to the specific antigen (SpA5).

How can researchers troubleshoot weak or absent signals when using SPAC16C9.05 antibody in Western blots?

When faced with weak or absent signals in Western blots using SPAC16C9.05 antibody, researchers should systematically investigate potential issues:

Sample Preparation Troubleshooting:

• Protein Extraction Efficiency:

  • Test alternative lysis methods (mechanical vs. enzymatic)

  • Add protease inhibitors to prevent degradation

  • Verify protein concentration using multiple quantification methods

• Protein Denaturation:

  • Increase SDS concentration in sample buffer

  • Extend heating time (5-10 minutes at 95°C)

  • Add reducing agent (DTT or β-mercaptoethanol) to disrupt disulfide bonds

Immunodetection Optimization:

• Antibody Dilution Series:

  • Test primary antibody concentrations from 1:250 to 1:2000

  • Try longer incubation (overnight at 4°C vs. 1-2 hours at room temperature)

• Signal Enhancement Methods:

  • Use high-sensitivity ECL substrate

  • Increase secondary antibody concentration or incubation time

  • Consider signal amplification systems (biotin-streptavidin)

• Transfer Efficiency Verification:

  • Stain membrane with Ponceau S after transfer

  • Use pre-stained molecular weight markers to confirm transfer

  • Try different membrane types (PVDF vs. nitrocellulose)

Common Issues and Solutions Table:

This troubleshooting approach is consistent with the methodology used in antibody characterization described in search result .

What are the critical considerations when analyzing immunofluorescence data for SPAC16C9.05 localization during different cell cycle stages?

When analyzing SPAC16C9.05 subcellular localization across the cell cycle using immunofluorescence, researchers should consider these methodological aspects:

Cell Cycle Stage Identification:

• Morphological Markers:

  • Cell length and width measurements

  • Nuclear morphology (DAPI staining)

  • Septum formation (calcofluor white staining)

• Molecular Markers:

  • Co-staining with cell cycle-specific proteins (e.g., Cdc13 for G2/M)

  • DNA content analysis

Quantitative Image Analysis Approach:

• Signal Intensity Measurement:

  • Define regions of interest (ROI) for subcellular compartments

  • Calculate mean fluorescence intensity within ROIs

  • Normalize to background and total cellular staining

• Co-localization Analysis:

  • Calculate Pearson's or Manders' coefficients with marker proteins

  • Perform line scan analysis across cells

  • Use object-based co-localization for punctate structures

• Dynamic Localization Quantification:

  • Track intensity ratios between compartments across cell cycle stages

  • Measure nuclear/cytoplasmic ratios

  • Quantify distances from reference structures

Statistical Analysis Guidelines:

• Analyze minimum 50-100 cells per cell cycle stage

• Perform 3+ biological replicates

• Apply appropriate statistical tests (ANOVA with post-hoc tests)

• Create visualization tools (box plots, scatter plots with overlay of cell cycle stage)

Potential Artifacts and Controls:

• Autofluorescence control (unstained cells)

• Secondary antibody-only control

• Fixation-dependent localization changes

• Z-stack acquisition to avoid focal plane bias

This methodological approach follows principles similar to those used in immunohistochemistry applications mentioned in search result .

How can researchers integrate SPAC16C9.05 antibody-based studies with genomic and proteomic approaches to build comprehensive models of protein function?

To develop comprehensive models of SPAC16C9.05 protein function, researchers should integrate antibody-based studies with multi-omics approaches:

Integration Framework:

• Antibody-Based Functional Analysis:

  • Immunoprecipitation coupled with mass spectrometry to identify protein interactions

  • ChIP-seq to map genomic binding sites (if DNA-binding protein)

  • Immunofluorescence to determine subcellular localization

  • Phospho-specific antibodies to track post-translational modifications

• Genomic Data Integration:

  • RNA-seq to correlate SPAC16C9.05 levels with gene expression profiles

  • CRISPR screens to identify genetic interactions

  • Motif analysis of ChIP-seq data to determine DNA-binding preferences

• Proteomic Correlation:

  • Quantitative proteomics following SPAC16C9.05 depletion or overexpression

  • Phosphoproteomics to map signaling pathways

  • Structural prediction and modeling based on protein interaction data

Data Analysis Pipeline:

• Multi-omics Data Processing:

  • Normalize data across platforms

  • Apply batch correction methods

  • Use consistent statistical thresholds across datasets

• Network Construction and Visualization:

  • Build protein-protein interaction networks

  • Integrate with known pathways

  • Apply graph theory algorithms to identify key nodes

• Functional Prediction Models:

  • Machine learning approaches to predict function from integrated data

  • Gene Ontology enrichment analysis

  • Comparative analysis with orthologs in other species

This integrated approach mirrors the comprehensive methodology seen in search result , where researchers combined antibody characterization with structural modeling and functional validation to develop a complete understanding of antibody-antigen interactions and function.

How might novel structural biology approaches enhance our understanding of SPAC16C9.05 antibody epitopes?

Similar to the approach described in search result where researchers used AlphaFold2 and molecular docking to predict antibody-antigen interactions, SPAC16C9.05 antibody epitope research can benefit from advanced structural biology techniques:

Advanced Structural Analysis Methods:

• Computational Structure Prediction:

  • Use AlphaFold2 or RoseTTAFold to generate theoretical 3D structures

  • Apply molecular docking to predict antibody-antigen binding interfaces

  • Simulate binding energetics with molecular dynamics

• Experimental Structure Determination:

  • X-ray crystallography of antibody-antigen complexes

  • Cryo-EM for visualization of larger complexes

  • Hydrogen-deuterium exchange mass spectrometry to map binding interfaces

• Epitope Mapping Technologies:

  • Alanine scanning mutagenesis to identify critical binding residues

  • Peptide array analysis to define linear epitopes

  • Phage display for conformational epitope mapping

Implementation Strategy:

• Generate computational models of SPAC16C9.05 protein using AlphaFold2

• Dock antibody models to predicted structures

• Identify potential epitopes from docking results

• Validate predicted epitopes through experimental approaches

• Use validated structural information to design improved antibodies or peptide competitors

This approach follows the methodology described in search result , where researchers used "alphafold2 method" to construct 3D theoretical structures and molecular docking to predict binding epitopes, which were then experimentally validated.

What role could SPAC16C9.05 antibodies play in understanding evolutionary conservation of protein function across yeast species?

Antibodies against SPAC16C9.05 can serve as valuable tools for comparative studies across yeast species to understand protein evolution and functional conservation:

Cross-Species Analysis Methodology:

• Epitope Conservation Assessment:

  • Align SPAC16C9.05 protein sequences from multiple yeast species

  • Identify conserved and divergent epitope regions

  • Test antibody cross-reactivity with orthologs from related species

• Functional Conservation Studies:

  • Compare subcellular localization patterns across species

  • Evaluate interaction partners in different yeasts

  • Assess functional complementation in cross-species experiments

• Evolutionary Analysis Framework:

  • Map antibody epitopes to protein domains with known functions

  • Correlate epitope conservation with functional conservation

  • Analyze selection pressure on epitope-containing regions

Experimental Approach:

• Perform Western blots on lysates from multiple yeast species

• Compare immunofluorescence localization patterns across species

• Conduct immunoprecipitation studies from different yeasts

• Create phylogenetic trees based on epitope conservation

• Correlate antibody binding with functional assays